McCallion John D., EVP & Chief Financial Officer, subtracted 2,669 shares of MetLife, Inc. (MET) from its portfolio at the rate of $44.43 per share valuing $118,592 on Feb 12. The insider left behind 17,869 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of MetLife, Inc. (MET) was $47.29. Currently, the 1st Resistance Point for this stock is $48.05, with a 2nd Resistance Point sitting at $48.81. Meanwhile, this company’s stock has a 1st Support Level at $46.78 and a 2nd Support Level at $46.27. MetLife, Inc. (MET) stock has lost -$3.40, or -6.71%, in the past five days. In the last full month, these shares have lost -$2.71, or -5.42%. In the past three months, this stock’s price has fallen by -$0.12, or -0.25%. This year-to-date, MetLife, Inc. (MET) shares have gained $6.23, or 15.17%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For MetLife, Inc. (MET) stock, 50% of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 50% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 100 – 200 Day MACD Oscillator % of long-term indicators suggest that this stock is a “.”
With 950,369 K shares outstanding, this company currently has a market capitalization of $44,942,952K. MetLife, Inc. (MET) generates $67,941 M in annual sales, amounting to annual net income of $5,123 M. This stock has generated a 1-Year Total Return of 2.38%, a 3-Year Total Return of 28.74%, and a 5-year Total Return of 2.45%. This stock’s 5-Year Dividend Growth is 64.36%, with its most recent dividend valued at $0.440 per share on 08/05/19. Its Annual Dividend Yield is 3.72%, and its Annual Dividend Rate is 1.76.
In the most recently-reported fiscal quarter, which ended in Mar-19, MetLife, Inc. (MET) reported earnings of $1.48 per share. Wall Street analysts, on average, were expecting the company to report earnings of $1.27 per share, representing a 0.21 difference and 16.14% surprise. In the previous quarter ending in Dec-18, the reported earnings of $1.35 represented a 0.07 difference from the consensus estimate calling for $1.28 per share, which was a 5.23% surprise.
For the current fiscal quarter, which is set to end in 09/2019, the average earnings estimate is $1.41 per share. This estimate came from a total of 5 Wall Street Analysts. Of those market experts, the high estimate was $1.45 and the low estimate was $1.38. In the year-ago quarter, MetLife, Inc. (MET) generated per-share earnings of $1.38. If the analysts are correct about the current quarter’s earnings, the growth will be +2.17%.
Turning our focus now to insider trading activity, there have been 21 purchases (10,647 shares in total) and 0 sale (0 shares in total) in the last 3 months. In the last 6 months, there have been 79 insider buys amounting to 409,844 shares and 39 insider sales amounting to 206,250 shares. In the past full year, 123 insider purchases were made (involving 621,183 shares) and 41 insider sell-offs equivalent to 334,738 shares.
Moving onto liquidity, MetLife, Inc. (MET) has a Current Ratio of 2.09. Looking at this company’s capital structure, its Total Debt to Total Equity is 32.81, its Total Debt to Total Capital is 24.70, and its Total Debt to Total Assets is now 2.50. Looking even further ahead into the future, its Long-Term Debt to Equity is 32.30 and its Long-Term Debt to Total Capital is 24.32.